IPO

Explore the landscape of IPO in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on IPO to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

NMPA Approves Lilly's Jaypirca (Pirtobrutinib) as First‑Line Monotherapy for CLL/SLL – Non‑Covalent BTK Inhibitor Completes Line‑of‑Therapy Progression in China
CompanyDrug

NMPA Approves Lilly’s Jaypirca (Pirtobrutinib) as First‑Line Monotherapy for CLL/SLL – Non‑Covalent BTK Inhibitor Completes Line‑of‑Therapy Progression in China

Eli Lilly and Company (NYSE: LLY) announced that China's National Medical Products Administration (NMPA) has officially approved a new indication for its non‑covalent (reversible) BTK inhibitor Jaypirca (pirtobrutinib), as a…

Sino Biopharmaceutical's CTTQ Partners With STADA on Pembrolizumab Biosimilar TQB3570 – Exclusive European License With Options Across Oncology and Immunology

Sino Biopharmaceutical’s CTTQ Partners With STADA on Pembrolizumab Biosimilar TQB3570 – Exclusive European License With Options Across Oncology and Immunology

Sinovac and Egypt's GENNVAX Launch sIPV Technical Cooperation Project in Beijing – Sabin Inactivated Polio Vaccine Localization Deal Enters Implementation Phase

Sinovac and Egypt’s GENNVAX Launch sIPV Technical Cooperation Project in Beijing – Sabin Inactivated Polio Vaccine Localization Deal Enters Implementation Phase

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Medlander Medical Technology’s IPO Raises RMB 1 billion on Shanghai’s STAR Board

CompanyDeals

United Imaging Healthcare’s STAR Listing Raises USD1.85 Billion

CompanyDeals

Sinotherapeutics Inc. to Raise RMB600m via STAR Board IPO for Generic Drug Expansion

CompanyDeals

MicuRx Pharmaceuticals Completes RMB1.06B IPO for Antibacterial Drug Development

CompanyDeals

HeNan Genuine Biotech Files for IPO to Fund Azvudine Commercialization

CompanyDeals

3D Medicines Files IPO Prospectus for Hong Kong Listing

CompanyDeals

InventisBio Raises USD 308M in Shanghai STAR IPO, Valued at USD 1.54B

CompanyDeals

Innovita Biological Technology’s IPO Raises USD 131.3M for POCT Expansion

Show More